AVITA Medical sells RECELL, a skin cell device for wound care, plus PermeaDerm and Cohealyx wound matrices to burn and trauma centers. It last closed at $15.77 on Nov 17, up 3.61% on the day. RCEL reports earnings on Thu, Feb 11, 2027. The average 12-month price target from 3 analysts is $21.00 (+33.2% from the last close), with a high of $22.00 and a low of $20.00. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell).
Each firm's latest rating on RCEL in the past 90 days
Average 12-month target
$21.00
▲ 33.2% upside
Based on 3 analysts who set a price target on RCEL in the past 90 days. The average target is $21.00, with a high of $22.00 and a low of $20.00, compared with the last close of $15.77.
Low $20.00Avg $21.00High $22.00
Blue marker: last close $15.77
Highest target$22.00
Average target$21.00
Lowest target$20.00
Latest rating changes
TD CowenTarget raised
Nov 12Buy$14 → $22
Lake StreetTarget raised
Nov 7Buy$12 → $20
BTIGTarget raised
Nov 6Buy$15 → $21
BTIGTarget raised
Oct 12Buy$11 → $15
Lake StreetTarget raised
Aug 28Buy$6 → $12
Date
Firm
Action
Rating
Price target
Nov 12
TD Cowen
Target raised
Buy
$14 → $22
Nov 7
Lake Street
Target raised
Buy
$12 → $20
Nov 6
BTIG
Target raised
Buy
$15 → $21
Oct 12
BTIG
Target raised
Buy
$11 → $15
Aug 28
Lake Street
Target raised
Buy
$6 → $12
Loading…
Technical Analysis
RCEL · as of the Nov 17 close · updated after every close
Uptrend
The stock sits between its 20 and 50 day averages. It is 54% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 54). The nearest support is the Pivot at $15.70, and the nearest resistance the 20 day average at $16.03.
Short trendBullish
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityHigh, 7.2%/day
Key levels
$18.4352 week high+16.9%
$16.90Swing high (Oct 29)+7.2%
$16.34Pivot R1+3.6%
$16.0320 day average+1.6%
$15.77Last close
$15.70Pivot−0.4%
$15.13Pivot S1−4.1%
$14.67Swing low (Nov 2)−7.0%
$13.5950 day average−13.8%
$10.20100 day average−35.3%
$7.27200 day average−53.9%
$3.2252 week low−79.6%
Indicators
RSI (14)
54.05
Middle of its range
Neutral
MACD
0.71
Below its signal line
Bearish
Stochastic
23.1
Middle of its range
Neutral
ADX (14)
31.9
Trending up
Williams %R
-70.7
Oversold below −80, overbought above −20
Neutral
CCI (20)
-32.4
Oversold below −100, overbought above 100
Neutral
Rate of change
+2.9%
Change over 10 sessions
Bullish
ATR (14)
$1.14
Typical daily range, 7.3% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
Uptrend, overbought
Short trendBullish
Long trendBullish
MomentumStrong
StretchOverbought
VolatilityNormal, 10.6%/day
Key levels
$18.4352 week high+16.9%
$16.90Swing high (Oct 29)+7.2%
$16.34Pivot R1+3.6%
$16.0320 day average+1.6%
$15.77Last close
$15.70Pivot−0.4%
$15.13Pivot S1−4.1%
$14.67Swing low (Nov 2)−7.0%
$13.5950 day average−13.8%
$10.20100 day average−35.3%
$7.27200 day average−53.9%
$3.2252 week low−79.6%
Indicators
RSI (14)
76.22
Overbought above 70
Overbought
MACD
2.81
Above its signal line
Bullish
Stochastic
79.8
Middle of its range
Neutral
ADX (14)
61.2
Strong uptrend
Williams %R
-24.8
Oversold below −80, overbought above −20
Neutral
CCI (20)
99.2
Oversold below −100, overbought above 100
Neutral
Rate of change
+59.6%
Change over 10 sessions
Bullish
ATR (14)
$1.67
Typical daily range, 10.6% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for RCEL
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how RCEL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow RCEL usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How RCEL has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2012.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RCEL is in one of them and how their past RCEL trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About AVITA Medical
AVITA Medical is an acute wound care company based in Valencia, California. Its main product is RECELL, a device that lets clinicians prepare a suspension of a patient's own skin cells at the point of care, which can cover large wounds using a small donor skin sample. The company also sells PermeaDerm, a biosynthetic wound matrix, and Cohealyx, a dermal matrix made from collagen. Its customers are mainly burn, trauma and surgical centers, chiefly in the United States.